University Hospitals Coventry and Warwickshire (UHCW) is reviewing the care of hundreds of patients following concerns that many received years of unnecessary chemotherapy. The trust has issued an apology to patients and their families.
A Royal College of Physicians (RCP) review of 20 cases revealed that patients were severely harmed. Some were reportedly misdiagnosed, while others were wrongly told they would die if they stopped taking temozolomide.
Mark Callaghan, from Leicester, developed leukaemia after being prescribed temozolomide for a brain tumour for almost 13 years at UHCW. This was more than 12 years longer than NHS guidance typically recommends. Mr Callaghan stated he was not warned that leukaemia was a potential side effect of the treatment.
Prof Andy Hardy, UHCW chief executive, acknowledged that the failings should have been identified and stopped earlier. He stated that changes have been implemented to prevent a recurrence of the situation. Coventry East MP Mary Creagh has expressed shock at the findings and is seeking an urgent meeting with trust managers.
Both Prof Ian Brown, the consultant who prescribed the treatment, and clinical nurse specialist Ian Edwards have retired from UHCW. Neither has responded to attempts by the BBC to contact them.